Predicting ROR1/BCL2 Combination Targeted Therapy of Small Cell Carcinoma of the Lung

被引：0
|
作者：
Wang, W. [1 ]
Shilo, K. [1 ]
Amann, J. [1 ]
Shulman, A. [1 ]
Hojjat-Farsangi, M. [2 ]
Mellstedt, H. [2 ]
Schultz, J. [3 ]
Croce, C. [1 ]
Carbone, D. [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Karolinska Inst, Stockholm, Sweden
[3] Kancera Ab, Solna, Sweden
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
SCLC; ROR1; Combinatorial Therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P47.10
引用
收藏
页码：S496 / S496
页数：1
相关论文
共 50 条
  • [1] Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung
    Wang, Walter Z.
    Shilo, Konstantin
    Amann, Joseph M.
    Shulman, Alyssa
    Hojjat-Farsangi, Mohammad
    Mellstedt, Hakan
    Schultz, Johan
    Croce, Carlo M.
    Carbone, David P.
    [J]. CELL DEATH & DISEASE, 2021, 12 (06)
  • [2] Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung
    Walter Z. Wang
    Konstantin Shilo
    Joseph M. Amann
    Alyssa Shulman
    Mohammad Hojjat-Farsangi
    Håkan Mellstedt
    Johan Schultz
    Carlo M. Croce
    David P. Carbone
    [J]. Cell Death & Disease, 12
  • [3] The role of Bcl2 in non small cell lung carcinoma
    Mulholland, K
    Maxwell, P
    Graham, ANJ
    Spence, G
    McManus, KG
    McGuigan, JA
    Bharucha, H
    [J]. JOURNAL OF PATHOLOGY, 2001, 195 : 39A - 39A
  • [4] ROR1 and ROR2 in human malignancies: potentials for targeted therapy
    Rebagay, Guilly
    Yan, Su
    Liu, Cheng
    Cheung, Nai-Kong
    [J]. FRONTIERS IN ONCOLOGY, 2012, 2
  • [5] Investigating the roles of ROR1/2 in non-small cell lung carcinoma NSCLC and potential therapeutic applications
    Pan, Wen-An
    Guo, Xin
    Galang, Christina
    Ko, Mira
    Kucharski, Jeff
    Miller, Nicole
    Moskowitz, Haim
    Watkins, Jeff
    Lannutti, Brian
    Jessen, Katti
    Liu, Hao
    [J]. CANCER RESEARCH, 2024, 84 (07)
  • [6] High-Level ROR1 and BCL2, Cancer-Stemness, and BCL2 Mutations Associate with Venetoclax Resistance in Chronic Lymphocytic Leukemia
    Ghia, Emanuela M.
    Rassenti, Laura Z.
    Choi, Michael Y.
    Chu, Elvin
    Widhopf, George F., II
    Kipps, Thomas J.
    [J]. BLOOD, 2019, 134
  • [7] Targeting ROR1 in combination with osimertinib in EGFR mutant lung cancer cells
    Nakagawa, Nozomu
    Miyake, Noriko
    Ochi, Nobuaki
    Yamane, Hiromichi
    Takeyama, Masami
    Nagasaki, Yasunari
    Ikeda, Tomoko
    Yokota, Etsuko
    Fukazawa, Takuya
    Nakanishi, Hidekazu
    Harada, Daijiro
    Kiura, Katsuyuki
    Takigawa, Nagio
    [J]. EXPERIMENTAL CELL RESEARCH, 2021, 409 (02)
  • [8] Prognostic value of Bcl2 expression in small cell lung carcinomas.
    Ashfaq, R
    Amirkhan, R
    Saboorian, MH
    [J]. LABORATORY INVESTIGATION, 1997, 76 (01) : 935 - 935
  • [9] Expression of Bax and Bcl2 proteins in small cell lung cancer (SCLC)
    Badzio, A.
    Krajewska, M.
    Elsaleh, H.
    Kowalczyk, A.
    Kurowski, K.
    Jassem, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Artemin-Stimulated Progression of Human Non-Small Cell Lung Carcinoma Is Mediated by BCL2
    Tang, Jian-Zhong
    Kong, Xiang-Jun
    Kang, Jian
    Fielder, Graeme C.
    Steiner, Michael
    Perry, Jo K.
    Wu, Zheng-Sheng
    Yin, Zhinan
    Zhu, Tao
    Liu, Dong-Xu
    Lobie, Peter E.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2010, 9 (06) : 1697 - 1708
12345